RNU6-718P

Across TCGA pan-cancer cohorts, RNU6-718P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-718P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-718P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-718P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ACC, CESC, and LIHC are the cancer types where RNU6-718P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.114	0.892	<.001	72	view →
CESC	OS	Tertile	II,III,IV	0.146	0.759	.004	72	view →
LIHC	DFS	Tertile	All	0.086	0.555	<.001	72	view →
LUAD	OS	Tertile	II,III,IV	0.223	0.749	.013	45	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	36	view →
UCS	OS	Tertile	IV	0.269	0.624	.042	36	view →
HNSC	OS	Tertile	II,III,IV	0.236	0.672	.039	36	view →
ESCA	DFS	Tertile	III,IV	1.000	0.277	.027	27	view →
LAML	DFS	Tertile	All	0.201	0.453	.014	18	view →
STAD	OS	Tertile	III,IV	0.159	0.502	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-718P–ACC (OS)

Open the ACC breakdown →